Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 8.69
-0.40 (-4.40%)
Jun 12, 2026, 10:02 AM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 271.63 million as of June 12, 2026. Its market cap has decreased by -11.33% in one year.
Market Cap
271.63M
Enterprise Value
307.03M
Revenue
179.06M
Ranking
n/a
PE Ratio
51.77
Stock Price
8.69
Market Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 271.63M, a decrease of -69.77%. That is a compound annual growth rate of -9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 271.63M | -7.22% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 827.24M |
| MegaPro Biomedical | 796.07M |
| Neith | 791.43M |
| BioLASCO Taiwan | 768.36M |
| SynCore Biotechnology Co.,Ltd | 720.87M |
| TaiwanJ Pharmaceuticals | 607.32M |
| Vectorite Biomedical | 569.03M |
| LAUNXP Biomedical | 554.98M |